DLK1

DLK1 Molekülinformation

Englischer Name	Protein delta homolog 1	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	2	Target-Alias	DLK1，DLK-1，DLK1 protein
Höchste Forschungs- und Entwicklungsphase	Phase 1 Clinical

Englischer Name	Protein delta homolog 1
Target-Alias	DLK1，DLK-1，DLK1 protein
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	2
Höchste Forschungs- und Entwicklungsphase	Phase 1 Clinical

DLK1 Produktliste

Attribut
Protein (2)
Produktbibliothek
Online (2)
Spezies
Human (1)Cynomolgus (1)
Etikett
His Tag (2)
Marker
Unconjugated (2)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
DK1-H52H3	Human	HEK293	Human DLK1 / FA1 Protein, His Tag (MALS verified)				In den Warenkorb legen
DK1-C52H7	Cynomolgus	HEK293	Cynomolgus DLK1 / FA1 Protein, His Tag				In den Warenkorb legen

Gesamtmenge2

DLK1 Molekülhintergrund

Protein delta homolog 1 is a protein that in humans is encoded by the DLK1 gene. It is expressed as a transmembrane protein, but a soluble form cleaved off by ADAM17 is active in inhibiting adipogenesis, the differentiation of pre-adipocytes into adipocytes.

DLK1 Molekülalias

DLK1,FA1,Protein delta homolog 1,Pg2,Fetal antigen 1

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
CBA-1205	CBA-1205	Phase 1 Clinical	Chiome Bioscience Inc	Carcinoma, Hepatocellular; Liver Neoplasms; Lung Neoplasms; Melanoma; Neoplasms; Neuroblastoma; Solid tumours	Details
ADCT-701	ADCT-701; ADCT701; LIV-1205 ADC	Phase 1 Clinical	Adc Therapeutics Sa, Cancer Research Technology	Adrenocortical Carcinoma; Carcinoma, Neuroendocrine; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Neuroblastoma; Neuroendocrine Tumors; Small Cell Lung Carcinoma	Details